Home > PB Ratio > NEULAND LABORATORIES

NEULAND LABORATORIES
PB (Price/Book ) Ratio

The Current P/B Ratio of NEULAND LABORATORIES is 14.83.

Share Price ₹14,864.3Nov 19,2024
Market Cap ₹19,026.3 Cr
Book Value₹1,282.7 CrMar2024 - Consolidated Results
Price/Book 14.83xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PB (Price/Book ) ratio of NEULAND LABORATORIES

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of NEULAND LABORATORIES is calculated as :

Current Market Cap [ ₹19,026.3 Cr] as on Nov 19,2024

(/) Book Value [ ₹1,282.7 Cr] based on Mar2024 - Consolidated Results

(=) P/B Ratio [ 14.83x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for NEULAND LABORATORIES , the investors are currently willing to pay '14.83 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of NEULAND LABORATORIES !

The chart below summarizes the trend in P/B Ratio of NEULAND LABORATORIES over the last five years.

Historical PB (Price/Book ) ratio chart of NEULAND LABORATORIES


PB Ratio Performance Analysis for NEULAND LABORATORIES

- NEULAND LABORATORIES 's latest p/b ratio is 14.83x.

- NEULAND LABORATORIES 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.82x.

- NEULAND LABORATORIES 's operated at median p/b ratio of 2.32x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, NEULAND LABORATORIES 's p/b ratio peaked in Mar2024 at 6.29x.

- NEULAND LABORATORIES 's p/b ratio hit its five-year low in Mar2020 of 0.51x.


How does NEULAND LABORATORIES 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
NEULAND LABORATORIES 1,282.7014.8319,026.3
SUN PHARMACEUTICAL INDUSTRIES LTD63,666.806.69425,930.0
CIPLA LTD26,619.904.46118,828.0
DR REDDYS LABORATORIES LTD28,123.503.60101,290.0
ZYDUS LIFESCIENCES LTD19,829.504.8095,280.3
DIVIS LABORATORIES LTD13,571.0011.53156,524.0
MANKIND PHARMA LTD9,339.8411.02102,890.0
TORRENT PHARMACEUTICALS LTD6,856.1515.28104,742.0
LUPIN LTD14,175.806.5692,929.7
AUROBINDO PHARMA LTD29,842.802.4372,478.2
ABBOTT INDIA LTD3,658.7315.7957,784.9

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs NEULAND LABORATORIES 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.43x
Max industry PB 15.79x
Median industry PB 6.69x
Average industry PB 8.82x



You may also like the below Video Courses